Author:
Inoue Yuta,Matsumoto Yu,Toh Kazuko,Miyano Kazuki,Cabral Horacio,Igarashi Kazunori,Iwasaki Shinichi,Kataoka Kazunori,Yamasoba Tatsuya
Funder
Ministry of Education, Culture, Sports, Science and Technology
Astellas Foundation for Research on Metabolic Disorders
Japan Society for the Promotion of Science
Japan Science and Technology Corporation
Reference46 articles.
1. Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the global burden of disease study;C. Global Burden of Disease Cancer;JAMA Oncol.,2017
2. A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs;Matsumura;Cancer Res.,1986
3. Cancer nanomedicine: progress, challenges and opportunities;Shi;Nat. Rev. Cancer,2017
4. Tumor targeting via EPR: strategies to enhance patient responses;Golombek;Adv. Drug Deliv. Rev.,2018
5. Nanomedicine of synergistic drug combinations for cancer therapy - strategies and perspectives;Zhang;J. Control. Release,2016
Cited by
9 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献